biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > One Thing

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 23, 2023 5:27pm

115 Views

Post# 35240859

RE:RE:One Thing

Hah haha! Uncle, don't read it. Ignore it.

Better, if you have a thought, post it.

But I doubt you have one.

Harrassment! Good one. Love it.

It would be a shame if anything should interrupt the lamentations of unclepieman.

jd

<< Previous

Bullboard Posts

Next >>

Cannabix advances marijuana breathalyzer tech